Plandai Benefits From Industry's EGCG Alzheimer Studies

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Plandai Benefits From Industry's EGCG Alzheimer Studies

BALTIMORE, MD--(Marketwired - Jun 6, 2013) - Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, reports that a recent study published in in the Journal of Biology Chemistry found that Epigallocatechin gallate (EGCG) has demonstrated the ability to serve as a treatment for Alzheimer's disease, which could serve as a major positive for Plandai. EGCG is the most abundant catechin found in green tea and serves as a key component of the Company's flagship offering. Plandai Biotechnology is a developer of highly bioavailable, phytonutrient rich extracts (like EGCG), which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions.

The Alzheimer study, which occurred in the lab, was shown to stop amyloid-beta proteins from attaching to and killing brain cells in a lab setting by changing the shape of the proteins by applying ECGC. These proteins have been identified in many studies and trials as proteins that play a role in the disease. The Alzheimer's Association notes that Alzheimer's disease is the sixth-leading cause of death in the United States and the only cause of death among the top 10 in the U.S. that cannot be prevented, cured or even slowed. As a result, according to the National Institutes of Health, over 1,000 clinical trials are underway to fight this disease, which affects 5 million people in the U.S. and is expected to nearly triple by 2050.

Clearly, additional studies will be undertaken to eventually confirm these early results in a human clinical trial setting. Given that Plandai's Phytofare™ is engineered to produce extremely high bioavailability and pharmaceutical-grade purity, Plandai could emerge as a primary source of ECGC via its Phytofare™ Catechin Complex for these studies. Moreover, these encouraging results could prompt greater consumption of green tea and its antioxidant extracts as an Alzheimer's preventive tool. Therefore, producers touting ECGC's properties in such treatments could select Plandai as a large scale, go-to source of extract in its offerings, serving as a boon to Plandai's business and industry status.

Additional detail via the Goldman Small Cap Research article as well as associated disclaimers can be accessed or downloaded in their entirety by visiting www.goldmanresearch.com .

About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock research reports, daily stock market blogs, and popular investment newsletters. For more information, visit www.goldmanresearch.com .

A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com .

About Plandai Biotechnology, Inc. ( OTCQB : PLPL ): Plandai Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts, which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing the patented Phytofare™ extracts in-house allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include food and beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com .

Goldman Small Cap Research Rob Goldman Analyst 410-609-7100 rob@goldmanresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 244

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 385

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 324

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 273

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 234

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 430

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

HUB Cyber Security's Roadmap for Revolutionary Financial Solutions

Updated Category News Views 164

HUB Cyber Security Unveils Revolutionary Financial Solutions HUB Cyber Security Ltd. (Nasdaq: HUBC) has shared an ambitious roadmap to launch the HUB Token (HUBT), positioning itself as a pioneer in the rapidly evolving digital finance landscape. This strategic initiative aims to power the innovative Trvsthub™ platform, which promises to enhance the security and...

Continue Reading
MSU Energy Completes Successful Exchange Offer for Senior Notes

Updated Category News Views 227

MSU Energy Completes Successful Exchange of Senior Notes MSU Energy S.A. has announced the results of its recent exchange offer, which culminated successfully within an established timeframe. This initiative involved an exchange for up to $218,973,000 in aggregate principal amount of its existing 6.875% Senior Notes due 2025. The transition to new financial instruments...

Continue Reading
Major Defense Contracts Awarded to Lockheed and Boeing

Updated Category News Views 304

The Pentagon's New Contracts The recent contracts awarded by the Pentagon to Lockheed Martin Corporation (NYSE: LMT) and Boeing Company (NYSE: BA) exemplify the ongoing investment in national defense. These new agreements underscore a robust financial commitment to enhancing military capabilities. Lockheed Martin's Taiwan FMS Award Lockheed Martin has secured a pivotal...

Continue Reading
Maryland Army National Guard's General Birckhead to Address Graduates

Updated Category News Views 134

General Janeen L. Birckhead to Inspire Graduates at HCC Columbia, MD — A significant moment is approaching for over 1,100 graduates of Howard Community College (HCC) as they prepare to celebrate their accomplishments at the upcoming commencement exercises. The keynote speaker for this year's ceremony is none other than Major General Janeen L. Birckhead, Adjutant General...

Continue Reading
SUNation Energy Announces Participation in Annual Roth Conference

Updated Category News Views 133

SUNation Energy to Engage in Investment Discussions SUNation Energy, Inc. (Nasdaq: SUNE), a prominent provider of solar energy and power solutions, has made it's presence known as it prepares to take part in a significant investor conference. The upcoming event, known as the Annual Roth Conference, serves as a pivotal platform where growth companies showcase their...

Continue Reading